- /
- Supported exchanges
- / US
- / STSEY.PINK
Stratec SE (STSEY PINK) stock market data APIs
Stratec SE Financial Data Overview
Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and integrating instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Stratec SE data using free add-ons & libraries
Get Stratec SE Fundamental Data
Stratec SE Fundamental data includes:
- Net Revenue: 260 M
- EBITDA: 39 695 K
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-09-30
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Stratec SE News
New
How Recent Price Target Cuts Are Reframing The Story For Stratec (XTRA:SBS)
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. The latest research on Stra...
How Subtle Shifts Are Reframing The Story For Stratec (XTRA:SBS)
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. The latest update to the Stratec stock story centers on a revised price target, resh...
Stratec (ETR:SBS) shareholders have endured a 81% loss from investing in the stock five years ago
Long term investing is the way to go, but that doesn't mean you should hold every stock forever. We really hate to see fellow investors lose their hard-earned money. Imagine if you held Stratec SE (ET...
Are Stratec SE's (ETR:SBS) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?
It is hard to get excited after looking at Stratec's (ETR:SBS) recent performance, when its stock has declined 22% over the past three months. We, however decided to study the company's financials to ...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.